Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

被引：3

作者：

Beasley, Richard ^{[1
,2
]}

Harper, James ^{[1
]}

Masoli, Matthew ^{[3
]}

机构：

[1] Med Res Inst New Zealand, Wellington 6242, New Zealand

[2] Capital & Coast Dist Hlth Board, Wellington, New Zealand

[3] Univ Exeter, Royal Devon & Exeter Hosp, Exeter, Devon, England

来源：

LANCET RESPIRATORY MEDICINE | 2020年 / 8卷 / 05期

关键词：

BENRALIZUMAB; ANTIBODY; SAFETY;

D O I：

10.1016/S2213-2600(20)30051-5

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：425 / 427

页数：4

共 10 条

[1]

Bernstein JA, 2020, LANCET RESP MED

[2] Randomised controlled trials in severe asthma: selection by phenotype or stereotype [J].

Brown, Thomas ;

Jones, Thomas ;

Gove, Kerry ;

Barber, Clair ;

Elliott, Scott ;

Chauhan, Anoop ;

Howarth, Peter ;

Aitkin, L. ;

Babu, S. ;

Dennison, P. ;

Djukanovic, R. ;

Grainge, C. ;

Hewitt, L. ;

Jayasekera, N. ;

Kurukulaaratchy, R. ;

Kerley, S. ;

Lau, L. ;

Laws, D. ;

Owen, J. ;

Ray, E. ;

Reynish, D. ;

Rupani, H. ;

Scullion-Win, O. .

EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (06)

[3] Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma [J].

Busse, William W. ;

Katial, Rohit ;

Gossage, David ;

Sari, Suha ;

Wang, Bing ;

Kolbeck, Roland ;

Coyle, Anthony J. ;

Koike, Masamichi ;

Spitalny, George L. ;

Kiener, Peter A. ;

Geba, Gregory P. ;

Molfino, Nestor A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) :1237-1244

[4] Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies [J].

FitzGerald, J. Mark ;

Bleecker, Eugene R. ;

Menzies-Gow, Andrew ;

Zangrilli, James G. ;

Hirsch, Ian ;

Metcalfe, Paul ;

Newbold, Paul ;

Goldman, Mitchell .

LANCET RESPIRATORY MEDICINE, 2018, 6 (01) :51-64

[5] Placebo Effects in Clinical Trials Evaluating Patients with Uncontrolled Persistent Asthma [J].

Luc, Faye ;

Prieur, Emily ;

Whitmore, G. A. ;

Gibson, Peter G. ;

Vandemheen, Katherine L. ;

Aaron, Shawn D. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (09) :1124-1130

[6] A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma [J].

Nowak, Richard M. ;

Parker, Joseph M. ;

Silverman, Robert A. ;

Rowe, Brian H. ;

Smithline, Howard ;

Khan, Faiz ;

Fiening, Jon P. ;

Kim, Keunpyo ;

Molfino, Nestor A. .

AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (01) :14-20

[7] Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial [J].

Patel, Mitesh ;

Pilcher, Janine ;

Pritchard, Alison ;

Perrin, Kyle ;

Travers, Justin ;

Shaw, Dominick ;

Holt, Shaun ;

Harwood, Matire ;

Black, Peter ;

Weatherall, Mark ;

Beasley, Richard .

LANCET RESPIRATORY MEDICINE, 2013, 1 (01) :32-42

[8] Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial [J].

Pavord, Ian D. ;

Korn, Stephanie ;

Howarth, Peter ;

Bleecker, Eugene R. ;

Buhl, Roland ;

Keene, Oliver N. ;

Ortega, Hector ;

Chanez, Pascal .

LANCET, 2012, 380 (9842) :651-659

[9] Co-morbidities in severe asthma: Clinical impact and management [J].

Porsbjerg, Celeste ;

Menzies-Gow, Andrew .

RESPIROLOGY, 2017, 22 (04) :651-661

[10] Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma A Systematic Review and Meta-analysis [J].

Sobieraj, Diana M. ;

Weeda, Erin R. ;

Nguyen, Elaine ;

Coleman, Craig I. ;

White, Michael ;

Lazarus, Stephen C. ;

Blake, Kathryn V. ;

Lang, Jason E. ;

Baker, William L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14) :1485-1496

← 1 →